LAM RESEARCH CORPORATION (LRCX) FY2025 Q1 Balance Sheet

Balance Sheet

As of 2024-09-29

Swipe to see the full flow
LAM RESEARCH CORPORATION (LRCX) FY2025 Q1 Balance SheetBalance sheet as of 2024-09-29. The chart shows assets, liabilities and equity at that date.Current liabilities$5.34 BLiabilities$11.06 BNon-current liabilities$5.72 BCurrent assets$13.49 BEquity$8.47 BAssets$19.53 BGross equity(calculated)$33.93 BNon-current assets$6.04 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsInventoriesAccounts receivable, less allowance of $5,580 as of September 29, 2024, and $5,277 as of June 30, 2024Prepaid expenses and other current assetsProperty and equipment, netOther assetsGoodwill and intangible assetsAccrued expenses and other current liabilitiesDeferred profitTrade accounts payableCurrent portion of long-term debt and finance lease obligationsLong-term debt and finance lease obligations, less current portionIncome taxes payableOther long-term liabilitiesRetained earningsAdditional paid-in capitalCommon stock, at par value of $0.001 per share; authorized, 4,000,000 shares as of September 29, 2024 and June 30, 2024; issued and outstanding, 1,291,958 shares as of September 29, 2024, and 1,303,769 shares as of June 30, 2024Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost; 1,660,250 shares as of September 29, 2024, and 1,648,239 shares as of June 30, 2024Accumulated other comprehensive lossCurrent liabilitiesCurrent liabilities$5.34 BAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$2.20 BDeferred profitDeferred profit$1.94 BLiabilitiesLiabilities$11.06 BTrade accounts payableTrade accounts payable$704.25 MCurrent portion of long-term debt and finance lease obligationsCurrent portion of long-term debtand finance lease obligations$504.68 MNon-current liabilitiesNon-current liabilities$5.72 BLong-term debt and finance lease obligations, less current portionLong-term debt and finance lease obligations, net$4.48 BCurrent assetsCurrent assets$13.49 BEquityEquity$8.47 BIncome taxes payableIncome taxes payable$664.72 MAssetsAssets$19.53 BCash and cash equivalentsCash and cash equivalents$6.07 BOther long-term liabilitiesOther long-term liabilities$574.13 MGross equity (calculated)Gross equity(calculated)$33.93 BInventoriesInventories$4.21 BAccounts receivable, less allowance of $5,580 as of September 29, 2024, and $5,277 as of June 30, 2024Accounts receivable, net$2.94 BPrepaid expenses and other current assetsPrepaid expenses and other current assets$277.80 MNon-current assetsNon-current assets$6.04 BRetained earningsRetained earnings$25.63 BProperty and equipment, netProperty and equipment, net$2.21 BOther assetsOther assets$2.07 BGoodwill and intangible assetsGoodwill and intangible assets$1.76 BAdditional paid-in capitalAdditional paid-in capital$8.30 BCommon stock, at par value of $0.001 per share; authorized, 4,000,000 shares as of September 29, 2024 and June 30, 2024; issued and outstanding, 1,291,958 shares as of September 29, 2024, and 1,303,769 shares as of June 30, 2024Common stock$1.29 MTreasury stock, at cost; 1,660,250 shares as of September 29, 2024, and 1,648,239 shares as of June 30, 2024Treasury stock−$25.37 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$87.80 M
Chart details

LAM RESEARCH CORPORATION (LRCX) FY2025 Q1 Balance Sheet

Balance sheet as of 2024-09-29. The chart shows assets, liabilities and equity at that date.

Assets
19,532,489,000 US dollars
Current assets
13,492,368,000 US dollars
Non-current assets
6,040,121,000 US dollars
Liabilities
11,060,598,000 US dollars
Current liabilities
5,342,668,000 US dollars
Non-current liabilities
5,717,930,000 US dollars
Equity
8,471,891,000 US dollars
Cash and cash equivalents
6,067,471,000 US dollars
Inventories
4,209,878,000 US dollars
Accounts receivable, less allowance of $5,580 as of September 29, 2024, and $5,277 as of June 30, 2024
2,937,217,000 US dollars
Prepaid expenses and other current assets
277,802,000 US dollars
Property and equipment, net
2,214,269,000 US dollars
Other assets
2,067,508,000 US dollars
Goodwill and intangible assets
1,758,344,000 US dollars
Accrued expenses and other current liabilities
2,196,424,000 US dollars
Deferred profit
1,937,315,000 US dollars
Trade accounts payable
704,247,000 US dollars
Current portion of long-term debt and finance lease obligations
504,682,000 US dollars
Long-term debt and finance lease obligations, less current portion
4,479,087,000 US dollars
Income taxes payable
664,717,000 US dollars
Other long-term liabilities
574,126,000 US dollars
Retained earnings
25,630,045,000 US dollars
Additional paid-in capital
8,303,014,000 US dollars
Common stock, at par value of $0.001 per share; authorized, 4,000,000 shares as of September 29, 2024 and June 30, 2024; issued and outstanding, 1,291,958 shares as of September 29, 2024, and 1,303,769 shares as of June 30, 2024
1,292,000 US dollars
Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding
0 US dollars
Treasury stock, at cost; 1,660,250 shares as of September 29, 2024, and 1,648,239 shares as of June 30, 2024
negative 25,374,657,000 US dollars
Accumulated other comprehensive loss
negative 87,803,000 US dollars
Gross equity (calculated)
33,934,351,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
LAM RESEARCH CORPORATION (LRCX) FY2025 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!